Evidence map›Paper›PMID 32159069›Full record

ReviewJournal of the American Academy of Orthopaedic Surgeons. Global research & reviews2020

Controversial Topics in Total Knee Arthroplasty: A Five-Year Update (Part 2).

Johannes Michiel van der Merwe, Matthew Semrau Mastel

Abstract readReview
In one paragraph

Review in Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Significant increase in quantity and quality of knee arthroplasty related research in KSSTA over the past 15 years.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Johannes Michiel van der MerweAdult Reconstruction (Dr. van der Merwe), Department of Orthopaedics, University of Saskatchewan, and the Department of Orthopaedics (Dr. Mastell), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Matthew Semrau MastelAdult Reconstruction (Dr. van der Merwe), Department of Orthopaedics, University of Saskatchewan, and the Department of Orthopaedics (Dr. Mastell), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review article examines updates to the literature during the past 5 years on numerous topics which were felt to have ongoing controversy. These topics include venous thromboprophylaxis, tranexamic acid usage, tourniquet usage, and wound closure techniques. Methods: For each individual topic, a literature search was conducted on several databases with emphasis on studies that were published in the past 5 years. Preference was given to meta-analyses and randomized controlled trials. Results: Tranexamic acid is a safe and effective treatment modality, and consideration should be given to use multiple doses and combine different modes of administration. Certain treatment modalities (skin sutures, limited or no tourniquet usage) can cause greater patient satisfaction at a cost of longer operating times. Postoperative anticoagulation is still a very controversial topic. There is however some evidence suggesting prolonging anticoagulation to 35 days postoperative. Conclusions: By analyzing the results of the aforementioned studies, surgeons can implement the most up-to-date evidence-based care when doing total knee arthroplasty surgery. However, many of these selected topics continue to have a component of ongoing controversy with no definitive conclusions developed in recent literature.

Indexed as

AnticoagulantsAntifibrinolytic AgentsArthroplasty, Replacement, KneeAspirinBlood Loss, SurgicalFactor Xa InhibitorsHeparinHeparin, Low-Molecular-WeightHumansPlatelet Aggregation InhibitorsTourniquetsTranexamic AcidVenous ThromboembolismWarfarinWound Closure TechniquesAnticoagulantsAntifibrinolytic AgentsAspirinFactor Xa InhibitorsHeparinHeparin, Low-Molecular-WeightPlatelet Aggregation InhibitorsTranexamic AcidWarfarin

Identifiers

PMID32159069
PMCPMC7028789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.